1. Home
  2. NBIX vs PAYC Comparison

NBIX vs PAYC Comparison

Compare NBIX & PAYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • PAYC
  • Stock Information
  • Founded
  • NBIX 1992
  • PAYC 1998
  • Country
  • NBIX United States
  • PAYC United States
  • Employees
  • NBIX N/A
  • PAYC N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • PAYC Computer Software: Prepackaged Software
  • Sector
  • NBIX Health Care
  • PAYC Technology
  • Exchange
  • NBIX Nasdaq
  • PAYC Nasdaq
  • Market Cap
  • NBIX 13.2B
  • PAYC 13.2B
  • IPO Year
  • NBIX 1996
  • PAYC 2014
  • Fundamental
  • Price
  • NBIX $128.91
  • PAYC $226.41
  • Analyst Decision
  • NBIX Strong Buy
  • PAYC Hold
  • Analyst Count
  • NBIX 22
  • PAYC 11
  • Target Price
  • NBIX $165.59
  • PAYC $230.00
  • AVG Volume (30 Days)
  • NBIX 935.9K
  • PAYC 477.6K
  • Earning Date
  • NBIX 07-30-2025
  • PAYC 08-06-2025
  • Dividend Yield
  • NBIX N/A
  • PAYC 0.66%
  • EPS Growth
  • NBIX 2.97
  • PAYC N/A
  • EPS
  • NBIX 3.39
  • PAYC 7.02
  • Revenue
  • NBIX $2,509,900,000.00
  • PAYC $1,913,800,000.00
  • Revenue This Year
  • NBIX $16.12
  • PAYC $10.03
  • Revenue Next Year
  • NBIX $15.06
  • PAYC $9.17
  • P/E Ratio
  • NBIX $38.04
  • PAYC $32.27
  • Revenue Growth
  • NBIX 18.42
  • PAYC 9.87
  • 52 Week Low
  • NBIX $84.23
  • PAYC $152.46
  • 52 Week High
  • NBIX $157.98
  • PAYC $267.76
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 46.34
  • PAYC 41.03
  • Support Level
  • NBIX $130.75
  • PAYC $233.15
  • Resistance Level
  • NBIX $137.44
  • PAYC $238.44
  • Average True Range (ATR)
  • NBIX 3.60
  • PAYC 4.49
  • MACD
  • NBIX -0.71
  • PAYC 0.57
  • Stochastic Oscillator
  • NBIX 33.88
  • PAYC 33.80

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About PAYC Paycom Software Inc.

Founded in 1998, Paycom Software Inc is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

Share on Social Networks: